Xiulong Xu
Department of General Surgery
Rush University Medical Center
1653 W
Congress Parkway
USA
Name/email consistency: high
- Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression. Xu, X., Rao, G.S., Groh, V., Spies, T., Gattuso, P., Kaufman, H.L., Plate, J., Prinz, R.A. BMC. Cancer (2011)
- Immunohistochemical detection of heparanase-1 expression in eutopic and ectopic endometrium from women with endometriosis. Xu, X., Ding, J., Ding, H., Shen, J., Gattuso, P., Prinz, R.A., Rana, N., Dmowski, W.P. Fertil. Steril. (2007)
- Estradiol induces heparanase-1 expression and heparan sulphate proteoglycan degradation in human endometrium. Xu, X., Ding, J., Rao, G., Shen, J., Prinz, R.A., Rana, N., Dmowski, W.P. Hum. Reprod. (2007)
- In vivo and in vitro degradation of heparan sulfate (HS) proteoglycans by HPR1 in pancreatic adenocarcinomas. Loss of cell surface HS suppresses fibroblast growth factor 2-mediated cell signaling and proliferation. Xu, X., Rao, G., Quiros, R.M., Kim, A.W., Miao, H.Q., Brunn, G.J., Platt, J.L., Gattuso, P., Prinz, R.A. J. Biol. Chem. (2007)
- Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer. Xu, X., Rao, G., Gaffud, M.J., Ding, H.G., Maki, G., Klingemann, H.G., Groh, V., Spies, T., Caillat-Zucman, S., Gattuso, P., Plate, J., Prinz, R.A. J. Clin. Endocrinol. Metab. (2006)
- High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines. Xu, X., Quiros, R.M., Gattuso, P., Ain, K.B., Prinz, R.A. Cancer Res. (2003)
- Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis. Xu, X., Quiros, R.M., Maxhimer, J.B., Jiang, P., Marcinek, R., Ain, K.B., Platt, J.L., Shen, J., Gattuso, P., Prinz, R.A. Clin. Cancer Res. (2003)
- In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide: mechanisms of action. Xu, X., Shen, J., Mall, J.W., Myers, J.A., Huang, W., Blinder, L., Saclarides, T.J., Williams, J.W., Chong, A.S. Biochem. Pharmacol. (1999)
- IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression. Xu, X., Fu, X.Y., Plate, J., Chong, A.S. Cancer Res. (1998)
